5=Excellent, 4=Very Good, 3=Good, 2=Fair, 1=Poor
54321
Identify how multiple barriers to glycemic control can be removed to achieve better patient.
Evaluate clinical roles of available insulin preparations and appropriate use in patient-centered treatment plans.
Design effective strategies for initiating, titrating, and identifying insulin therapy through disease spectrum
Review efficacy, novel benefits, safety and tolerability of emerging insulin therapies.
Ascertain potential impact of emerging insulin-based therapies on patient outcomes.
5=Strongly Agree, 4=Agree, 3=Neutral, 2=Disagree, 1=Strongly Disagree
54321
Overall, I was satisfied with this program.
The content was relevant to my practice.
The information presented was without promotional or commercial bias.
The information presented was scientifically rigorous and evidence based.
The information presented provided appropriate and effective opportunities for active learning (discussion, Q&A).
The information presented promoted improvements or quality in healthcare.
The quality of the educational process was satisfactory and appropriate.
The format of the discussion was relevant and enhanced my knowledge of the subject.
The format of the discussion was relevant and enhanced my competence to treat patients with Type 2 diabetes.
The faculty/speakers were effective.
I plan to make changes to my practice as a result of what I learned from this program.
5=Excellent, 4=Very Good, 3=Good, 2=Fair, 1=Poor
54321
James R. Gavin, III, MD, PhD
Richard E. Pratley, MD
Chantal Mathieu, MD, PhD